Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

MXCT

Maxcyte (MXCT)

Maxcyte Inc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:MXCT
DateTimeSourceHeadlineSymbolCompany
12/19/202411:26AMRNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
12/18/202410:31AMRNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
12/10/202412:16PMRNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
12/10/202412:12PMRNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
12/09/20247:29AMAlliance NewsAlliance NewsMaxCyte ups core revenue guidance for 2024 as eyes 2025 cost savingsLSE:MXCTMaxcyte Inc
12/09/20242:00AMRNS Regulatory NewsMaxCyte, Inc. MaxCyte Streamlines Operations and Raises GuidanceLSE:MXCTMaxcyte Inc
12/02/202412:09PMRNS Regulatory NewsMaxCyte, Inc. Total Voting Rights and Block Listing ReturnLSE:MXCTMaxcyte Inc
11/28/202410:05AMRNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
11/28/202410:05AMRNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
11/19/20244:49AMRNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
11/08/20249:41AMAlliance NewsAlliance NewsMaxCyte third-quarter profit falls amid surging costsLSE:MXCTMaxcyte Inc
11/07/20242:00AMRNS Regulatory NewsMaxCyte, Inc. Filing of 10Q formLSE:MXCTMaxcyte Inc
11/07/20242:00AMRNS Regulatory NewsMaxCyte, Inc. Third Quarter 2024 Financial ResultsLSE:MXCTMaxcyte Inc
11/06/20244:05PMUK RegulatoryMaxCyte Reports Third Quarter 2024 Financial Results and Updates Full Year 2024 GuidanceLSE:MXCTMaxcyte Inc
11/06/20248:43AMRNS Regulatory NewsMaxCyte, Inc. Exercise of options and PDMR dealingLSE:MXCTMaxcyte Inc
11/04/20248:23AMRNS Regulatory NewsMaxCyte, Inc. Total Voting RightsLSE:MXCTMaxcyte Inc
10/31/20248:05AMRNS Non-RegulatoryMaxCyte, Inc. Upcoming Investor ConferencesLSE:MXCTMaxcyte Inc
10/31/20243:00AMRNS Regulatory NewsMaxCyte, Inc. Exercise of options and PDMR dealingLSE:MXCTMaxcyte Inc
10/18/20244:24AMRNS Regulatory NewsMaxCyte, Inc. Grant of Options and Restricted Stock UnitsLSE:MXCTMaxcyte Inc
10/15/20248:05AMRNS Regulatory NewsMaxCyte, Inc. MaxCyte Appoints Cynthia Collins to BoardLSE:MXCTMaxcyte Inc
10/11/20248:00AMRNS Regulatory NewsMaxCyte, Inc. Notice of ResultsLSE:MXCTMaxcyte Inc
10/10/20248:05AMRNS Regulatory NewsMaxCyte, Inc. MaxCyte Appoints Ali Soleymannezhad as CCOLSE:MXCTMaxcyte Inc
10/03/20244:41AMRNS Regulatory NewsMaxCyte, Inc. Exercise of options and PDMR dealingLSE:MXCTMaxcyte Inc
10/01/20244:47AMRNS Regulatory NewsMaxCyte, Inc. Exercise of options and PDMR dealingLSE:MXCTMaxcyte Inc
10/01/20242:00AMRNS Regulatory NewsMaxCyte, Inc. Total Voting RightsLSE:MXCTMaxcyte Inc
09/27/202411:15AMRNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
09/27/202410:29AMRNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
09/20/202412:02PMRNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
09/16/20245:33AMAlliance NewsAlliance NewsMaxCyte touts strategic platform license deal with Kamau TherapeuticsLSE:MXCTMaxcyte Inc
09/16/20242:00AMRNS Regulatory NewsMaxCyte, Inc. TR-1: Notification of major holdingsLSE:MXCTMaxcyte Inc
 Showing the most relevant articles for your search:LSE:MXCT